Neurogene Inc. (NASDAQ: NGNE)
$36.4200
-35.1000 ( -49.10% ) 823.0K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$36.4200
Previous close
$71.5300
Volume
823.0K
Market cap
$582.62M
Day range
$36.3150 - $49.5450
52 week range
$12.4900 - $74.4900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 8-k | 8K-related | 13 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 8-k | 8K-related | 15 | Jun 03, 2024 |
| 8-k | 8K-related | 52 | May 10, 2024 |
| 10-q | Quarterly Reports | 80 | May 10, 2024 |
| 8-k | 8K-related | 15 | May 07, 2024 |
| def | Proxies and info statements | 22 | Apr 26, 2024 |
| ars | Annual reports | 1 | Apr 26, 2024 |
| 8-k | 8K-related | 13 | Apr 25, 2024 |